Mission

The Society for Translational Oncology (STO) is a professional association committed to speeding the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology by:

• Bringing knowledge and strategies for critical new developments in cancer treatment to the community oncologist.
• Bridging the “translational gap” between discovery and delivery of care to the patient.
• Providing educational activities to improve physician competencies and strategies for screening, prevention, diagnosis, treatment, and management of patients with cancer.

STO is led by a Board of world renowned oncologists.

A brief history of STO given by Dr. Martin J. Murphy Jr. during opening remarks 2010 STO Annual Meeting:

Collaboration in Cancer Drug Trials: Targets, Biomarkers, and Drugs Martin J. Murphy, DMedSc, PhD